一文盘点,谷丙转氨酶增高的8大原因

2022-09-09 王伯军大夫谈消化 王伯军大夫谈消化

谷丙转氨酶升高原因很多,有生理性的、也有病理性的。

谷丙转氨酶,是一项很常用的肝功能指标,很灵敏,有肝细胞损伤时就会增高。但谷丙转氨酶增高并不全是病理性的,也并不一定是肝脏损伤,其原因是多方面的。

Part 1

生理性谷丙转氨酶增高。如果在肝功能检查前剧烈运动、熬夜、休息不好、过度劳累、饮酒,吃过于油腻的食物,或者检查前没有保持空腹4~8个小时,这些生理性原因都会引起谷丙转氨酶升高。

这些生理性谷丙转氨酶增高,大多是轻度增高,去除原因后需要再复查,如果正常了,这就没关系,必不恐慌!但如果反复谷丙转氨酶增高,这可能是病理性的,就要仔细寻找其它原因了。

部分孕妇也可能发生谷丙转氨酶轻度增高,生完小孩就正常了,这也是生理性的。

Part 2

甲肝、乙肝、丙肝、戍肝等病毒性肝炎在病情发作时会造成肝脏受损,引起谷丙转氨酶升高。

Part 3

肝癌、肝硬化活动时,也会导致谷丙转氨酶升高。

Part 4

药物,服用了对肝脏有损害的药物,也会导致肝脏损伤,引起谷丙转氨酶升高。

Part 5

酒精肝、脂肪肝、自身免疫性肝炎等其它肝脏疾病也都会引起谷丙转氨酶升高。

Part 6

胆道疾病,胆囊炎、胆石症急性发作时,常有发热、腹痛、恶心、呕吐、黄疸、血胆红素及谷丙转氨酶升高,尤以胆总管结石发作时更为明显。

Part 7

心脏疾病,如急性心肌梗塞、心肌炎、心力衰竭时,也会出现谷丙转氨酶升高的情况。

Part 8

其他某些感染性疾病,如肺炎、伤寒、结核病、传染性单核细胞增多症等,都有谷丙转氨酶升高的现象。

总之,谷丙转氨酶升高原因很多,有生理性的、也有病理性的,有肝脏本身的、也有肝外的原因,需要结合病情具体分析,再做一些相应的检查以明确诊断,仿能针对性的治疗,才能取得较好的治疗效果。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-11 ms8000001408294061

    全面

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 ms9000001707791611

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 ms9000001707791611

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 仁医06
  5. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 liuxiaona
  6. [GetPortalCommentsPageByObjectIdResponse(id=1248344, encodeId=ce68124834421, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Sun Sep 11 07:35:36 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248035, encodeId=83a01248035d9, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248034, encodeId=feb8124803454, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af4d8295926, createdName=ms9000001707791611, createdTime=Fri Sep 09 06:47:07 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395482, encodeId=0297139548237, content=<a href='/topic/show?id=252d93386f8' target=_blank style='color:#2F92EE;'>#转氨酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93386, encryptionId=252d93386f8, topicName=转氨酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561671, encodeId=b80b15616e15d, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567680, encodeId=74c4156e68077, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Sep 09 06:28:11 CST 2022, time=2022-09-09, status=1, ipAttribution=)]
    2022-09-09 liuxiaona

相关资讯

Eur J Gastroen & Hepat:一种简单的非侵入性非酒精性脂肪性肝病肝纤维化评分系统

  非酒精性脂肪性肝病是一种常见疾病,许多患者的谷丙转氨酶水平正常。Stuart Mc Pherson医生称,现在需要一种用于进展期肝纤维化患者的有效的筛选方法,以便为患者提供专科护理。   研究小组对肝活检证实为非酒精性脂肪性肝病且谷丙转氨酶水平正常的病人进行非侵入性肝纤维化测试结果的评估。此研究包括研究小组对在1999~2009年间一家脂肪肝诊所的病人的评价。肝活检使用K